ANASTASIA AVERBUKH: Open Payments
NPI 1073903134 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,773 in 127 payments from 21 companies in 2025. Trend: 2023 $3,175 · 2024 $5,439 · 2025 $2,773
Food & beverage: $2,663Education: $110
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $529 |
| PFIZER INC. | 15 | $399 |
| ABBVIE INC. | 15 | $225 |
| Janssen Biotech, Inc. | 8 | $207 |
| E.R. Squibb & Sons, L.L.C. | 7 | $204 |
| Novartis Pharmaceuticals Corporation | 11 | $201 |
| Arcutis Biotherapeutics, Inc. | 17 | $171 |
| Regeneron Healthcare Solutions, Inc. | 5 | $138 |
| Organon LLC | 10 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: Bimzelx, CIBINQO, TREMFYA, Sotyktu, SKYRIZI, Zoryve, DUPIXENT, COSENTYX.
Industry payments across MO — which companies pay providers there.
